Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Rajewski

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Molecular Pharmacology|September 11, 2009
KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cellsShary N Shelton, Mary E Shawgo, Shawna B Matthews, et al.
BMC Cancer|November 2, 2011
Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cellsJeffery D Eskew, Takrima Sadikot, Pedro Morales, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Joel M Reid, Chad A Walden, Rui Qin, et al.
Ebiomedicine|November 7, 2017
Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers" [EBioMedicine 8 (2016) 117-131]Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Ebiomedicine|July 19, 2016
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven CancersAnuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Molecular Pharmacology|September 11, 2009
KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cellsShary N Shelton, Mary E Shawgo, Shawna B Matthews, et al.
BMC Cancer|November 2, 2011
Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cellsJeffery D Eskew, Takrima Sadikot, Pedro Morales, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Joel M Reid, Chad A Walden, Rui Qin, et al.
Ebiomedicine|November 7, 2017
Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers" [EBioMedicine 8 (2016) 117-131]Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Ebiomedicine|July 19, 2016
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven CancersAnuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Pageof 3